Showing posts with label Alzheimers. Show all posts
Showing posts with label Alzheimers. Show all posts

Feb 21, 2012

Debunking the Aluminum Foil Myth

The old myth was that aluminum foil and cookware is linked to Alzheimer's Disease. It has been around since the 1980s

This myth has its roots in research from the 1960s and 1970s that showed elevated levels of aluminum in the brains of Alzheimer's patients. For years people were warned off of aluminum pots and pans, and even aluminum foil to store food.

Since those studies a great deal of research has been done into what possible connections aluminum may have with Alzheimer's Disease, and failed to show any substantive link or connection between aluminum and risk for Alzheimer's Disease.

Most experts now believe any aluminum absorbed by the body is processed by the kidneys, urinated out, and it does not pose a threat for Alzheimer's Disease.

Dec 7, 2011

GPS Shoes

Here is a great idea for those who have someone with Alzheimer’s in the family. 5.4 million Americans are living with the disease with that figure predicted to rise to as many as 16 million by 2050, according to the Alzheimer’s Association. To make it easier for caregivers and family members to keep track, GTX Corp has partnered with comfort shoe manufacturer Aetrex to produce the GPS Shoe that allows real-time tracking of the wearer.

The company started out producing footwear for children with a miniaturized GPS chip and cellular device embedded in the sole that allowed parents to keep track via an online portal and then started offering similar shoes for long distance runners. It then realized the technology would also be beneficial in keeping track of those suffering dementia  and built its GPS technology into comfort and wellness shoes for the elderly. Sometimes technology is wizbang and practical.

Nov 6, 2010

Hospital Art

Believe it or not, art in hospitals has actually been found to aid the healing process while gloomy walls or the wrong kind of art can cause physical distress.

American Art Resources, a health-care art-consulting firm, says scientific studies show that art can aid in the recovery of patients, shorten hospital stays and help manage pain. Of course it has to be the right art. Vivid paintings of landscapes, friendly faces and familiar objects can lower blood pressure and heart rate, while abstract pictures can have the opposite effect.

In 1984, scientists found that postoperative patients healed more quickly and successfully if they had park-view windows. Through the 1980s, scientists became more interested in the role of art in hospitals.

Art can also be used to help patients on a more practical level. Autumn Leaves in Flower Mound, Texas, an Alzheimer's and dementia facility uses artwork to keep patients oriented to their surroundings.

Each of the four hallways has a different theme, which helps patients remember where their rooms are. Among them is a landscape hallway covered in outdoor settings and a Western hallway depicting images from the Old West.

Sep 24, 2010


Arrgh! Hope you enjoyed International Talk Like a Pirate Day Sep 19.
And today (September 24) is National Punctuation Day (sic)

Also, in case you forgot, World Alzheimer's Day was September 21.

Feb 18, 2010

Alzheimer's Drink

Rush University Medical Center is leading a nationwide clinical trial of a nutritional drink to determine whether it can improve cognitive performance in people with mild to moderate Alzheimer's. The study follows recently released results from an earlier trial conducted in Europe showing that the drink, called Souvenaid, improved verbal recall in people with mild disease who were followed for three months.

Results of the first European study were released recently, following publication in the journal Alzheimer's & Dementia. In that study, 225 patients with mild Alzheimer's were divided into two groups. Some drank Souvenaid and the others sipped a non-medical drink every day for 12 weeks.

Researchers found that the patients who drank Souvenaid improved in a delayed verbal recall task.

A total of 500 individuals who are taking medications approved by the U.S. Food and Drug Administration for the symptomatic treatment of mild to moderate Alzheimer's disease will be enrolled in the present study at 40 sites across the U.S. In the double-blinded study, half of the participants will drink about four ounces of Souvenaid once a day for 24 weeks. The other half will drink a control product that is similar in flavor, appearance, and composition, but without the Souvenaid nutrients. Neither group will know whether they are drinking Souvenaid or the other beverage.